Ann Coulter serves as the Preclinical Laboratory Manager at Pennington Biomedical Research Center, where she leverages her extensive background as a pharmaceutical research scientist and analytical chemist to spearhead innovative projects aimed at combating obesity, diabetes, and promoting youthful aging. With a solid foundation in...
Ann Coulter serves as the Preclinical Laboratory Manager at Pennington Biomedical Research Center, where she leverages her extensive background as a pharmaceutical research scientist and analytical chemist to spearhead innovative projects aimed at combating obesity, diabetes, and promoting youthful aging. With a solid foundation in chemical engineering and a keen entrepreneurial spirit, Ann is at the forefront of developing and patenting safe, long-term therapeutics that address these pressing health issues.
Currently, Ann is leading groundbreaking research focused on the discovery of natural compounds that enhance energy expenditure in human cells. This pivotal work has culminated in the formulation of a unique supplement that is now undergoing clinical trials. The supplement's novel molecular mechanism shows promise in stimulating weight loss and improving insulin sensitivity, positioning it as a potential game-changer in metabolic health. Ann's expertise in assay development and molecular biology is instrumental in optimizing these compounds for efficacy and safety, ensuring that they meet the rigorous standards required for clinical application.
In her role, Ann excels in early development and program management, effectively communicating complex scientific concepts to diverse stakeholders. Her proficiency in troubleshooting and both in vivo and in vitro methodologies allows her to navigate the challenges of preclinical research with agility. As she continues to drive the commercialization strategy for these innovative therapeutics, Ann's commitment to advancing health solutions reflects her dedication to improving quality of life through science and innovation.
